MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year book value per share growth
Latest
2.79%
↓ 94% vs avg
Percentile
P80
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
45.93%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 2.79% |
| Q3 2025 | -18.76% |
| Q2 2025 | -13.31% |
| Q1 2025 | -9.24% |
| Q4 2024 | -8.75% |
| Q3 2024 | -6.55% |
| Q2 2024 | -4.41% |
| Q1 2024 | 2.90% |
| Q4 2023 | -6.33% |
| Q3 2023 | -19.86% |
| Q2 2023 | 654.41% |
| Q1 2023 | -14.52% |
| Q4 2022 | -20.83% |
| Q3 2022 | -16.76% |
| Q2 2022 | 306.59% |
| Q1 2022 | 309.49% |
| Q4 2021 | -110.57% |
| Q3 2021 | -1.86% |
| Q2 2021 | -59.96% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |